Sure it was mentioned last November first.. #AVCT "The diagnostic business unit has also made good progress on a number of other non-COVID-19 commercial opportunities and on putting in place an ISO13485 accredited quality system to support the future growth."
RE: MHRA Manufacturer's Devices - Mologic Ltd6 Jun 2021 17:58
The sovereign test could well be a calibration of a mologic test using Avacta's affimers... Just saying.. In which case everybody involved will prevail.. Might get an RNS monday revealing more..
RE: MHRA Manufacturer's Devices - Mologic Ltd6 Jun 2021 17:03
I'm quite sure the mark up for odx with the rebranded mologic lft(visitect) will be more than producing the affidx lft. Avacta have never confirmed odx as a manufacturer of their affidx lft if I'm not mistaken. And there's no solid evidence to proof its going to be the sovereign test.(it did look that way in the past though) The wait might be down to getting pd passed off and making sure there's enough supply to pump out in the coming months. Also the fact the innova lft's haven't ran out of supply as of yet. To be honest I'm hoping avacta sell more to the EU. We are all aware of the governments delayed ever-changing actions..in here.
The only thing Jeremy has in common with a giant is a very large "Turd".. I'm alittle worried about Simonjames whereabouts. I'm thinking of putting a crowdfunder page together to start a search for him.
A seagull just dropped a giant green shoot on my mobile screen and you'd never believe it but i was on the avacta site news.. You couldn't make it up...
RE: MHRA Manufacturer's Devices - Mologic Ltd5 Jun 2021 16:25
Yes everything is pointing towards a release date shortly given the ending of supply of the inferior chinese lft's.. Second Generation lft's here we come...
MHRA Manufacturer's Devices - Mologic Ltd5 Jun 2021 14:36
Not sure if this has been spotted yet but I think the 'SARS-CoV-2 antigen IVD kit immunochromatographic test (ICT) rapid' has been added today. https://aic.mhra.gov.uk/era/pdr.nsf/vwLkupFileRef/9288?opendocument Its either authorisation for self testing for mologic or its a CE for Avacta.
I also feel its a limited market for this test as i just cant see it being given a CE mark for home testing approval. So its market would be for institutional purchases.... And lets not forget sepsis and Alzheimer’s test news to follow.. Thumbs up for the portfolio..
I'm pretty sure they would need CE approval and then sales could start if it is to be manufactured and sold. I'm personally thinking it will be sold off like pharm2farm. I know they speculated otherwise but i just can't see them going through all the partnership deals & T&T at this stage in the game. And they are already accustomed to dealing with quite a few big biotech companies.. Here's to hoping for a buyout in the next 6 months..
To be honest this share has more upside than its ever had before now.most of the risk has been taken care of.its at a historically low price considering we have a excellent Clinical validation result. The other old issue was the vulnerability of TB. But now he's practically sold down most his shares and will very likely buy back In Q3 or Q4. Profitable investments are all about timing and the its a Perfect time for investing in here if you feel its a good investment to be had. It ain't gonna get any lower imo.